SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-094565
Filing Date
2021-03-25
Accepted
2021-03-25 16:47:54
Documents
14
Period of Report
2021-03-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d164233d8k.htm   iXBRL 8-K 29303
2 EX-99.1 d164233dex991.htm EX-99.1 7182
6 GRAPHIC g164233dsp1.jpg GRAPHIC 3172
  Complete submission text file 0001193125-21-094565.txt   163539

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agio-20210325.xsd EX-101.SCH 3049
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agio-20210325_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agio-20210325_pre.xml EX-101.PRE 10939
7 EXTRACTED XBRL INSTANCE DOCUMENT d164233d8k_htm.xml XML 3236
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36014 | Film No.: 21772992
SIC: 2834 Pharmaceutical Preparations